Christine Tedijanto1, McKenna Nevers2, Matthew H Samore2, Marc Lipsitch1. 1. Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA. 2. Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA.
Abstract
BACKGROUND: Empirical antibiotic use is common in the hospital. Here, we characterize patterns of antibiotic use, infectious diagnoses, and microbiological laboratory results among hospitalized patients and aim to quantify the proportion of antibiotic use that is potentially attributable to specific bacterial pathogens. METHODS: We conducted an observational study using electronic health records from acute care facilities in the US Veterans Affairs Healthcare System. From October 2017 to September 2018, 482 381 hospitalizations for 332 657 unique patients that met all criteria were included. At least 1 antibiotic was administered at 202 037 (41.9%) of included hospital stays. We measured frequency of antibiotic use, microbiological specimen collection, and bacterial isolation by diagnosis category and antibiotic group. A tiered system based on specimen collection sites and diagnoses was used to attribute antibiotic use to presumptive causative organisms. RESULTS: Specimens were collected at 130 012 (64.4%) hospitalizations with any antibiotic use, and at least 1 bacterial organism was isolated at 35.1% of these stays. Frequency of bacterial isolation varied widely by diagnosis category and antibiotic group. Under increasingly lenient criteria, 10.2%-31.4% of 974 733 antibiotic days of therapy could be linked to a potential bacterial pathogen. CONCLUSIONS: Overall, the vast majority of antibiotic use could be linked to either an infectious diagnosis or microbiological specimen. Nearly one-half of antibiotic use occurred when there was a specimen collected but no bacterial organism identified, underscoring the need for rapid and improved diagnostics to optimize antibiotic use.
BACKGROUND: Empirical antibiotic use is common in the hospital. Here, we characterize patterns of antibiotic use, infectious diagnoses, and microbiological laboratory results among hospitalized patients and aim to quantify the proportion of antibiotic use that is potentially attributable to specific bacterial pathogens. METHODS: We conducted an observational study using electronic health records from acute care facilities in the US Veterans Affairs Healthcare System. From October 2017 to September 2018, 482 381 hospitalizations for 332 657 unique patients that met all criteria were included. At least 1 antibiotic was administered at 202 037 (41.9%) of included hospital stays. We measured frequency of antibiotic use, microbiological specimen collection, and bacterial isolation by diagnosis category and antibiotic group. A tiered system based on specimen collection sites and diagnoses was used to attribute antibiotic use to presumptive causative organisms. RESULTS: Specimens were collected at 130 012 (64.4%) hospitalizations with any antibiotic use, and at least 1 bacterial organism was isolated at 35.1% of these stays. Frequency of bacterial isolation varied widely by diagnosis category and antibiotic group. Under increasingly lenient criteria, 10.2%-31.4% of 974 733 antibiotic days of therapy could be linked to a potential bacterial pathogen. CONCLUSIONS: Overall, the vast majority of antibiotic use could be linked to either an infectious diagnosis or microbiological specimen. Nearly one-half of antibiotic use occurred when there was a specimen collected but no bacterial organism identified, underscoring the need for rapid and improved diagnostics to optimize antibiotic use.
Authors: Sebastian Schneeweiss; Ari Robicsek; Richard Scranton; Dan Zuckerman; Daniel H Solomon Journal: J Clin Epidemiol Date: 2006-12-18 Impact factor: 6.437
Authors: Katharina L van Santen; Jonathan R Edwards; Amy K Webb; Lori A Pollack; Erin O'Leary; Melinda M Neuhauser; Arjun Srinivasan; Daniel A Pollock Journal: Clin Infect Dis Date: 2018-07-02 Impact factor: 9.079
Authors: C M A van den Bosch; M E J L Hulscher; S Natsch; J Wille; J M Prins; S E Geerlings Journal: Clin Microbiol Infect Date: 2016-07-16 Impact factor: 8.067
Authors: Shelley S Magill; Jonathan R Edwards; Zintars G Beldavs; Ghinwa Dumyati; Sarah J Janelle; Marion A Kainer; Ruth Lynfield; Joelle Nadle; Melinda M Neuhauser; Susan M Ray; Katherine Richards; Richard Rodriguez; Deborah L Thompson; Scott K Fridkin Journal: JAMA Date: 2014-10-08 Impact factor: 56.272